Concepedia

Publication | Closed Access

Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan

55

Citations

26

References

2011

Year

Abstract

Tocilizumab may be a promising biologic agent in refractory ASD.

References

YearCitations

Page 1